Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-cell response to IL-7 in human tuberculosis

被引:37
|
作者
Lundtoft, Christian [1 ]
Awuah, Anthony Afum-Adjei [2 ,3 ]
Rimpler, Jens [1 ]
Harling, Kirstin [1 ]
Nausch, Norman [1 ]
Kohns, Malte [1 ]
Adankwah, Ernest [1 ]
Lang, Franziska [1 ]
Olbrich, Laura [1 ]
Mayatepek, Ertan [1 ]
Owusu-Dabo, Ellis [2 ,3 ]
Jacobsen, Marc [1 ]
机构
[1] Univ Childrens Hosp, Med Fac, Dept Gen Pediat Neonatol & Pediat Cardiol, Dusseldorf, Germany
[2] Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana
[3] KNUST, Sch Med Sci, Kumasi, Ghana
关键词
HIV-INFECTED PATIENTS; ACTIVE PULMONARY TUBERCULOSIS; CHRONIC VIRAL-INFECTION; INTERLEUKIN-7; RECEPTOR; ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; CD127; EXPRESSION; INFLAMMATORY CYTOKINES; MULTIPLE-SCLEROSIS; IMMUNE ACTIVATION;
D O I
10.1371/journal.ppat.1006425
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
T-cell proliferation and generation of protective memory during chronic infections depend on Interleukin-7 (IL-7) availability and receptivity. Regulation of IL-7 receptor (IL-7R) expression and signalling are key for IL-7-modulated T-cell functions. Aberrant expression of soluble (s) and membrane-associated (m) IL-7R molecules is associated with development of autoimmunity and immune failure in acquired immune deficiency syndrome (AIDS) patients. Here we investigated the role of IL-7/IL-7R on T-cell immunity in human tuberculosis. We performed two independent case-control studies comparing tuberculosis patients and healthy contacts. This was combined with follow-up examinations for a subgroup of tuberculosis patients under therapy and recovery. Blood plasma and T cells were characterised for IL-7/sIL-7R and mIL-7R expression, respectively. IL-7-dependent T-cell functions were determined by analysing STAT5 phosphorylation, antigen-specific cytokine release and by analysing markers of T-cell exhaustion and inflammation. Tuberculosis patients had lower soluble IL-7R (p < 0.001) and higher IL-7 (p < 0.001) plasma concentrations as compared to healthy contacts. Both markers were largely independent and aberrant expression normalised during therapy and recovery. Furthermore, tuberculosis patients had lower levels of mIL-7R in T cells caused by post-transcriptional mechanisms. Functional in vitro tests indicated diminished IL-7-induced STAT5 phosphorylation and impaired IL-7-promoted cytokine release of Mycobacterium tuberculosis-specific CD4(+) T cells from tuberculosis patients. Finally, we determined T-cell exhaustion markers PD-1 and SOCS3 and detected increased SOCS3 expression during therapy. Only moderate correlation of PD-1 and SOCS3 with IL-7 expression was observed. We conclude that diminished soluble IL-7R and increased IL-7 plasma concentrations, as well as decreased membrane-associated IL-7R expression in T cells, reflect impaired T-cell sensitivity to IL-7 in tuberculosis patients. These findings show similarities to pathognomonic features of impaired T-cell functions and immune failure described in AIDS patients.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Aberrant plasma IL-7 and soluble IL-7 receptor-α levels indicate impaired T-cell response to IL-7 in human tuberculosis
    Lundtoft, C.
    Awuah, A. Afum-Adjei
    Rimpler, J.
    Harling, K.
    Nausch, N.
    Kohns, M.
    Lang, F.
    Mayatepek, E.
    Owusu-Dabo, E.
    Jacobsen, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 201 - 201
  • [2] Interleukin 7 (IL-7) regulates IL-7 receptor levels in T lymphocytes.
    Appasamy, PM
    Jetty, V
    Valliappan, K
    Kenniston, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1178 - 1178
  • [3] Differential regulation of human IL-7 receptor α expression by IL-7 and TCR signaling
    Alves, Nuno L.
    van Leeuwen, Ester M. M.
    Derks, Ingrid A. M.
    van Lier, Rene A. W.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (08): : 5201 - 5210
  • [4] B-CELL IL-7 - HUMAN B-CELL LINES CONSTITUTIVELY SECRETE IL-7 AND EXPRESS IL-7 RECEPTORS
    BENJAMIN, D
    SHARMA, V
    KNOBLOCH, TJ
    ARMITAGE, RJ
    DAYTON, MA
    GOODWIN, RG
    BLOOD, 1993, 82 (10) : A241 - A241
  • [5] Rescue of Murine IL-7 Receptor Deficiency with Human IL-7 Receptor Gene Therapy
    Triebwasser, Michael
    Jarocha, Danuta Jadwiga
    Breda, Laura
    Fedorky, Megan
    Rivella, Stefano
    BLOOD, 2021, 138
  • [6] B-CELL IL-7 - HUMAN B-CELL LINES CONSTITUTIVELY SECRETE IL-7 AND EXPRESS IL-7 RECEPTORS
    BENJAMIN, D
    SHARMA, V
    KNOBLOCH, TJ
    ARMITAGE, RJ
    DAYTON, MA
    GOODWIN, RG
    JOURNAL OF IMMUNOLOGY, 1994, 152 (10): : 4749 - 4757
  • [7] REGULATION OF HUMAN T-CELL PROLIFERATION BY IL-7
    ARMITAGE, RJ
    NAMEN, AE
    SASSENFELD, HM
    GRABSTEIN, KH
    JOURNAL OF IMMUNOLOGY, 1990, 144 (03): : 938 - 941
  • [8] A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment
    Janot-Sardet, Caroline
    Assouline, Brigitte
    Cheynier, Remi
    Morre, Michel
    Beq, Stephanie
    JOURNAL OF IMMUNOLOGICAL METHODS, 2010, 353 (1-2) : 115 - 123
  • [9] Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours
    Al-Rawi, MAA
    Mansel, RE
    Jiang, WG
    HISTOLOGY AND HISTOPATHOLOGY, 2003, 18 (03) : 911 - 923
  • [10] REGULATION OF T-CELL PROLIFERATION BY IL-7
    GRABSTEIN, KH
    NAMEN, AE
    SHANEBECK, K
    VOICE, RF
    REED, SG
    WIDMER, MB
    JOURNAL OF IMMUNOLOGY, 1990, 144 (08): : 3015 - 3020